SCHUYLER KEVIN received a stock award from ADIAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/9/2026ACC: 0001213900-26-042052
Director
Since Jul 2018
+9.19K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
9.19K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.19K
Price / share
—
Trade value
—
% of position
32803.6%
4/7/2026
28.00→9.21K
Total
Net shares
+9.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/7/2026 | A · Award | +9.19K | — | — | 32803.6% | 28.00 | 9.21K |
| Total | +9.19K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned230.00
Common Stock
IndirectShares owned4.00
Total
234.00 indirect234.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 230.00 | Indirect |
| Common Stock | 4.00 | Indirect |
| Total | 234.00 | 234.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported